secwatch.observer — SEC 8-K summary
======================================

Issuer:     TJX COMPANIES INC /DE/ (TJX)
CIK:        0000109198
Form:       8-K
Filed at:   2023-09-22T23:59:59+00:00
Accession:  0000109198-23-000055
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

TJX elects Vertex CFO Charles F. Wagner Jr. to its Board of Directors
---------------------------------------------------------------------

- Charles F. Wagner, Jr., EVP and CFO of Vertex Pharmaceuticals, elected to TJX Board and Audit & Finance Committee effective Sept 20, 2023.
- Mr. Wagner receives standard non-employee director compensation including cash retainers and deferred stock awards.
- Deferred stock awards under SIP have total target value of $185,000, prorated for election date.
- Board determined Mr. Wagner independent per NYSE standards; no prior employment or disclosable transactions.
- No arrangements or understandings with any other person regarding his appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/109198/000010919823000055/0000109198-23-000055-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/109198/000010919823000055/tjx-20230920.htm
  HTML page:      https://secwatch.observer/filing/0000109198-23-000055

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer